Cleared Special

K042126 - PICC

K042126 is an FDA 510(k) clearance for PICC, manufactured by Arrow Intl., Inc.. The device is a Class 2 General Hospital device with product code LJS cleared through the Special 510(k) pathway after a 21-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2004
Decision
21d
Days
Class 2
Risk

K042126 is an FDA 510(k) clearance for the PICC. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Arrow Intl., Inc. (Reading, US). The FDA issued a Cleared decision on August 27, 2004 after a review of 21 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Arrow Intl., Inc. devices

FDA 510(k) Submission Details - K042126

510(k) Number K042126 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received August 06, 2004
Decision Date August 27, 2004
Days to Decision 21 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d faster than avg
Panel avg: 129d · This submission: 21d
Pathway characteristics
Modification to existing cleared device.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 190
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K042126.
BD ONECATH PERIPHERALLY INSERTED CENTRAL CATHETER
K042491 · Becton, Dickinson & CO · Nov 2004
TRIFUSION, MODEL 0609190/0659350
K041088 · C.R. Bard, Inc. · Nov 2004
PREMICATH, 1261.205
K041468 · Vygon Corp. · Sep 2004
ANGIODYNAMICS, INC. MORPHEUS PICC AND PROCEDURE KIT
K041420 · AngioDynamics, Inc. · Jul 2004
POWERPICC CATHETERS, MODELS 3175155, 3175135
K033389 · C.R. Bard, Inc. · Mar 2004
ANGIODYNAMICS, INC. MORPHEUS PICC AND PROCEDURE KIT
K040446 · AngioDynamics, Inc. · Mar 2004